Article Text
Therapeutics
Randomised controlled trial
The administration of corticosteroids to 34–36-week pregnant women at risk of imminent delivery does not reduce the risk of respiratory disorders in the newborn
Statistics from Altmetric.com
Context
A single course of antenatal corticosteroids (ACS) is an unusual example of an intervention which leads to a cost savings and an improved health outcome for infants born before 34-week gestational age (GA).1 However, the evidence with regards to its effectiveness in late preterm infants (those born between 34 and before 36 6/7 weeks) is unknown.
Methods
A single-centre, double-blind, randomised controlled trial of a single course of antenatal corticosteroids versus placebo in women at high risk of preterm birth between 34 and 36 6/7 weeks GA. Between April 2008 and June 2010, 320 women were randomised, 163 to ACS and 157 to placebo, at a large tertiary hospital in Recife, Brazil. Women randomised to …
Footnotes
-
Competing interests None.